Get started
Author

Margaret Fagan

ORCID: 0009-0008-4435-3322
Observed ORCID: 0009-0008-4435-3322
OpenAlex ID: A5102615602
Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial
2025 · Andrea M. Gross, Geraldine O’Sullivan Coyne, et al. · Nature Medicine · 57
PDF
Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics
2024 · R. Taylor Sundby, Jeffrey J. Szymanski, et al. · Clinical Cancer Research · 26
A Mixed Methods Study of Medication Adherence in Adults with Neurofibromatosis Type 1 (NF1) on a Clinical Trial of Selumetinib
2025 · Millicent S. Curlee, Mary Anne Toledo-Tamula, et al. · Cancers · 1
PDF
Data from Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics
2024 · R. Taylor Sundby, Jeffrey J. Szymanski, et al.
Supplementary Figure S3 from Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics
2024 · R. Taylor Sundby, Jeffrey J. Szymanski, et al.
Supplementary Figure S4 from Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics
2024 · R. Taylor Sundby, Jeffrey J. Szymanski, et al.
Supplementary Figure S2 from Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics
2024 · R. Taylor Sundby, Jeffrey J. Szymanski, et al.
Supplementary Figure S1 from Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics
2024 · R. Taylor Sundby, Jeffrey J. Szymanski, et al.
Supplementary Tables S1-S3 from Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics
2024 · R. Taylor Sundby, Jeffrey J. Szymanski, et al.
Works count: 9
Citation count: 84
H-index: 2
I10-index: 2
Year
Topic
Type